On June 12, 2024, AVAVA, Inc. closed the transaction. The company has raised $35,000,000 in this transaction. The transaction included participation from new investors, Jeisys Medical Inc., Catalio Structured Opportunities Fund, a fund managed by Catalio Capital Management, LP, new and existing investors.

The company has received $9,796,068 in its second and final tranche.